Advanced Medical Techniques

Today in Cell, we published new research showing how AI can help accelerate cancer discovery. With GigaTIME, we can now simulate spatial proteomics from routine pathology slides, enabling population-scale analysis of tumor microenvironments across dozens of cancer types and hundreds of subtypes.   Developed in partnership with Providence and the University of Washington, our hope is that this work helps scientists move faster from data to insight, revealing new links between genetic mutations, immune activity, and clinical outcomes, and ultimately improving health for people everywhere. https://lnkd.in/dSpPdtzz

The Ilizarov Apparatus: A Revolutionary Medical Innovation Developed in the 1950s by Dr. Gavriil Ilizarov, this external fixation device has transformed orthopedic surgery worldwide. The Ilizarov apparatus is a system of metal rings, rods, and fine wires that pass through bone, forming a stable external frame. It allows surgeons to gradually realign bones, correct deformities, and even lengthen limbs. Initially designed to treat complex fractures, it is now widely used for: Correcting bone deformities Limb lengthening Healing poorly healed fractures (nonunions) Treating severe bone infections The underlying principle is "distraction osteogenesis" — slowly separating bone segments to stimulate the natural growth of new bone tissue. Interestingly, the Ilizarov apparatus is also used in cosmetic surgeries, particularly for limb lengthening procedures. In countries like Russia, India, China, Turkey, and the United States, some individuals choose it for cosmetic height enhancement — a procedure that can add several centimeters to a person's stature. What makes the Ilizarov method remarkable is not just its mechanical precision, but its ability to unlock the body's regenerative potential — restoring mobility, correcting disabilities, and even changing lives in unexpected ways. #MedicalInnovation #Orthopedics #Healthcare #Ilizarov #Bones #Surgery #RegenerativeMedicine #Medicine #CosmeticSurgery #FollowMe #NowYouKnow

Posted with informed patient consent. This surgical content is shared solely for educational purposes.  Educational purposes. Together with Yoaav Krauthammer Krauthammer and our outstanding team at Deer Valley, we successfully performed the second ever robotic hybrid ablation for inappropriate sinus tachycardia (IST) at our DV Location. This marks a significant advancement in the procedural treatment of IST. IST is a complex, often underdiagnosed condition characterized by a persistently elevated heart rate (resting >100 bpm, 24-hour average >90 bpm) accompanied by symptoms like palpitations, dizziness, and reduced exercise tolerance. Standard therapies, beta blockers, ivabradine, and catheter ablation frequently produce suboptimal outcomes, with high recurrence rates and procedural complications. Our approach combined: • Robotic-assisted thoracoscopic access using the da Vinci Xi system • Direct pericardial visualization for enhanced precision and safety • Electrophysiological mapping using the Abbott HD Grid system • Targeted ablation of the sinoatrial node region based on earliest activation patterns Compared to traditional video-assisted thoracoscopic surgery (VATS), robotic-enhanced hybrid ablation offers superior visualization, access, and procedural control, reducing potential risks and improving operator ergonomics. This case demonstrates the potential of robotic hybrid approaches to redefine IST management, especially in patients with refractory disease or limited response to conventional treatments. Proud of our team’s commitment to pushing the boundaries of what’s possible in rhythm surgery. Follow Zain Khalpey, MD, PhD, FACS for more on Ai & Healthcare. #RoboticSurgery #HybridAblation #Electrophysiology #InappropriateSinusTachycardia #IST #CardiacSurgery #CardiothoracicSurgery #MinimallyInvasiveSurgery #ArrhythmiaManagement #HeartRhythm #MedicalInnovation #RoboticAssistedSurgery #Cardiology #EPCommunity #SurgicalInnovation #AdvancedMapping #SinusNodeAblation #daVinciSurgery #FutureOfSurgery #RoboticCardiacCare

Roche buys PathAI in big bet on AI-native diagnostics infrastructure: 🔘Roche is acquiring AI-powered digital pathology company PathAI in a deal worth up to $1.05bn, signalling continued pharma confidence that AI will become deeply embedded in diagnostics infrastructure, not just drug discovery and clinical development 🔘The deal builds on a partnership that started in 2021 and expanded into AI-enabled companion diagnostics in 2024, showing how many of these acquisitions are increasingly the result of long courtships rather than sudden AI shopping sprees 🔘PathAI focuses on digital pathology, where tissue samples are converted into high resolution digital images that AI can help analyse. The goal is not just speed and efficiency, but more precise and reproducible cancer diagnostics and treatment selection 🔘Roche appears to be making a broader strategic bet that pathology data will become a foundational layer for precision medicine, biomarker discovery, clinical trials and AI-enabled companion diagnostics, particularly in oncology 🔘One of the bigger themes here is the shift from AI as “software on top” toward AI-native workflows. Digital pathology potentially transforms pathology from a largely manual microscope-based process into a scalable data and analytics platform 🔘More broadly, pharma increasingly seems willing to buy AI capability rather than simply partner around it, with AstraZeneca and Modella AI a recent example of players trying to internalise AI, data and programmable biology capabilities rather than sit one step removed from them 💬It is another sign that future competitive advantage may not just come from owning drugs, but from owning the data, workflow and decision infrastructure around them #digitalhealth #ai #pharma

Last week, I read an article in NZZ about artificial intelligence and personalized cancer therapy, a topic that highlights both the long-standing ambitions and the current realities of precision medicine. For decades, precision medicine has promised treatments tailored to each individual. In reality, medicine has often had to rely on averages: what works for many, rather than what works for this person. In cancer care, this gap can be especially painful. Patients may endure therapies that ultimately do little good, while causing significant side effects. Researchers in Zurich are now exploring a different path. Instead of starting only with genetic data, they look at how a patient’s own cancer cells behave. Thousands of microscope images are generated after exposing these cells to different drugs. AI systems analyze these images and learn patterns that even trained experts cannot easily see. The result is not a single “magic answer,” but a ranked list of therapies that are most likely to work for that specific patient. What stands out is not only the technology, but the mindset behind it. This is not about replacing doctors with algorithms. It’s about augmenting human judgment with better tools. It’s about reducing guesswork. It’s about acknowledging how different each human body truly is. At the same time, the article is refreshingly honest. These approaches are not yet routine. Regulation, clinical validation, and real-world integration take time. Progress in medicine is rarely linear, and hype alone does not heal patients. And yet, something important is happening. AI is quietly shifting medicine from a reactive discipline toward a more anticipatory and compassionate one, where fewer patients have to go through treatments that won’t help them, and more receive therapies chosen with evidence tailored to their own biology. Innovation doesn’t have to be loud to be meaningful. Sometimes it’s careful. Sometimes it’s slow. And sometimes it’s deeply human. Curious to hear your thoughts: Where do you see AI making the most human difference in medicine? #artificialintelligence #AI #medicine #healthcare #precisioncare

AI in the OR is cutting costs—and complications. Here's how! Surgeons partnered with AI algorithms see 32% fewer complications during complex procedures. Every case without complications means one less extended hospital stay. Consider the financial impact. A single avoided complication saves hospitals approximately $8,300 per patient. Multiply this across thousands of procedures annually and the numbers become significant. Beyond cost savings, AI-assisted tools enhance surgical precision. They provide real-time feedback on instrument positioning, tissue identification, and critical decision points during procedures. Efficiency increases as well. Operating rooms utilizing AI systems report 18% faster turnover times between cases. This translates to more procedures performed daily without sacrificing quality or safety. Patient recovery accelerates with AI-optimized surgical approaches. Data shows an average reduction in hospital stays by 1.4 days when AI tools assist in surgical planning and execution. Medical device companies recognize this shift. Those integrating AI capabilities into their surgical tools gain market advantage as adoption increases across healthcare systems. For surgeons and OR staff, the learning curve proves worthwhile. Initial training investment yields consistent improvements in outcomes, ultimately reducing workload through fewer complications. Hospital administrators take note: implementing AI-assisted surgical platforms delivers return on investment typically within 14 months through combined efficiency gains and complication reductions. The future of surgery involves human expertise enhanced by artificial intelligence. Early adopters will benefit most as these systems continuously improve through machine learning from each procedure performed. Will your surgical team embrace AI tools to improve patient outcomes while reducing costs? The technology exists today, waiting only for implementation.

A new review highlights how #ArtificialIntelligence is transforming every stage of microsurgery, from detailed planning before an operation to guiding surgeons during it, and even monitoring patients afterwards. This is making complex reconstructive surgeries safer and more efficient. Key Facts:  📍Smarter Planning: AI helps surgeons identify tiny blood vessels (perforators) more quickly and accurately using imaging, reducing planning time significantly. It can also predict risks for patients and simulate surgical outcomes, improving patient understanding and consent. 📍Real-time Guidance: During surgery, AI-powered augmented reality (AR) can overlay crucial information onto the surgical field, like cutting guides for bone, improving precision and potentially reducing the need for expensive custom tools. AI also helps assess tissue health by analysing blood flow in real-time. 📍Post-Op Monitoring: After surgery, AI-driven smartphone apps can continuously monitor free flaps for signs of complications, detecting issues like insufficient blood flow with high accuracy (over 90% sensitivity) even before they're obvious to the human eye. 📍Future Potential: While more large-scale studies are needed, AI is set to redefine surgical procedures, making them safer, more precise, and more effective for patients. By MDPI https://lnkd.in/diq7b3sq Implication: This integration of AI into microsurgery represents a major step toward data-driven, precision surgery—enhancing outcomes, reducing complications, and laying the groundwork for a new standard of surgical care. #Microsurgery #AIinHealthcare #MedicalInnovation #SurgicalTech #HealthcareTechnology

🎯 Can a Micro-Device Save a Life Faster Than Traditional Surgery? New Medical Research Suggests It Can 🧠🩸⚡🌈 📊 The Journal of Stroke & Cerebrovascular Diseases (2024) reports that rapid clot removal increases survival rates by up to 43% when intervention happens within the first golden hour. 🧪 A Harvard–Mass General study showed that micro-rotational thrombectomy devices can reduce clot fragmentation risks by 31%, compared to older catheter methods. 🩺 Meanwhile, Johns Hopkins biomedical engineers found that controlled negative-pressure suction applied at micro-scale reduces vessel trauma by 27%, leading to safer outcomes in emergency procedures. 💡 These breakthroughs are part of a growing field known as micro-interventional medicine, where tiny precision devices outperform traditional surgical tools in speed, safety, and recovery time. ✨ What makes these systems so revolutionary? 🌈 Ultra-precise suction that targets clots without stressing vessel walls ⚡ Rotational micro-blades engineered to minimize residual debris 🧬 Smart sensor feedback that adjusts pressure in real time 🔬 Compact designs shaped by computational fluid dynamics 💎 Lower risk, higher response speed, and dramatically improved patient outcomes 🌟 This is the new frontier of emergency care — where physics, engineering, and medicine converge to restore blood flow in seconds rather than minutes. 🔬 Medical researchers now call these innovations “life-scale devices”: small enough to sit on a fingertip, powerful enough to reverse catastrophic events like strokes or embolisms. 🌈 Imagine a world where every ambulance, every ER, every remote clinic has access to such micro-devices. Not just innovation — life preservation at the speed of science. 💭 A question worth reflecting on: If technology can restore a blocked artery in seconds… how many lives could be rewritten? Credits: 🌟 All write-up is done by me (P.S. Mahesh) after in-depth research. All rights for visuals belong to respective owners. 📚

The Ilizarov method remains one of the most advanced and effective #orthopedic techniques for #bone lengthening and deformity correction. Originally developed by Dr. Gavriil Ilizarov, this circular external fixation system uses the principle of distraction osteogenesis—stimulating new bone growth through gradual, controlled tension. Whether treating congenital limb length discrepancies, post-traumatic deformities, or complex non-unions, the Ilizarov technique provides unmatched precision in bone regeneration and alignment. Its success lies in biomechanics, biology, and patient-specific customization—an intersection where orthopedic science meets surgical artistry. #medicaldevices #healthcareleaders